MLRT News and Press, Metalert Inc. From 02/15/23

MetAlert (OTC: MLRT) is a pioneer in location-sensitive health monitoring devices and wearable technology products for remote patient monitoring. “MetAlert is looking to achieve ‘some big things’ in 2023. Speaking in an interview with Sequire Spotlight published Dec. 28, C...

A recent study carried out by UTHealth Houston investigators has revealed that the presence of apathy in patients suffering from mild cognitive impairments may be a precursor to Alzheimer’s disease. Alzheimer's is a debilitating mental disorder that usually causes memory loss, poor judgm...

MetAlert (OTC: MLRT) , a pioneer in location-sensitive health monitoring devices and wearable technology products, developed GPS SmartSole(R), a medical monitoring device integrated into an orthotic insole, facilitating discreet tracking and remote monitoring of those living with Alzheimer’...

MetAlert, a developer of personal protective medical equipment and supplies, owes much of its growth to acting on feedback from real-world caregivers who use its products for the monitoring and tracking of vulnerable patients This connection with caregivers has yielded advanced products such as...

GPS-enabled location device developer MetAlert provides geographical tracking technology that is discrete and functional through shoe inserts that provide data connectivity to cognitive patient caregivers MetAlert announced in January that it is expanding the reach of its SmartSole flagship pro...

MetAlert (OTC: MLRT) is a pioneer in location-sensitive health devices and wearable technology products for remote patient monitoring. The company “has, since inception, sought to offer quality-of-life improvements to patients and consumers who have Alzheimer’s, dementia and autism...

Heart disease is one of the most prolific killers in America, taking one life every 34 seconds and affecting nearly one-half of the country’s population. According to a new study from the University of California, San Francisco, people who develop heart disease earlier in their lives h...

Wearable wellness technology innovator MetAlert is revitalizing its brand and increasing its product and services portfolio through M&A and other corporate developments designed to improve the company’s healthcare profile The mortality associated with chronic disease can be ameliorat...

Autism spectrum disorder (ASD) is a developmental disability that usually results in repetitive or restricted behavior as well as problems with social interaction and communication. The Centers for Disease Control and Prevention (CDC) estimates that around 2.21% of adults in America live on th...

MetAlert (OTC: MLRT) today announced the launch of its new 4G GPS SmartSole in Sweden through its distribution partner Posifon AB. The upgraded GPS SmartSole introduction will be an important part of the national service agreement Posifon recently secured with major municipalities across Sweden ...